TD Asset Management Inc. Raises Position in Monsanto Co. (MON)
TD Asset Management Inc. increased its position in Monsanto Co. (NYSE:MON) by 7.8% during the third quarter, Holdings Channel reports. The institutional investor owned 249,461 shares of the company’s stock after buying an additional 18,014 shares during the period. TD Asset Management Inc.’s holdings in Monsanto were worth $25,495,000 as of its most recent filing with the SEC.
A number of other institutional investors have also made changes to their positions in MON. WFG Advisors LP increased its position in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock worth $104,000 after buying an additional 158 shares during the period. Signaturefd LLC increased its position in shares of Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock worth $112,000 after buying an additional 415 shares during the period. Mycio Wealth Partners LLC increased its position in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares during the period. Pinkerton Retirement Specialists LLC increased its position in shares of Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock worth $114,000 after buying an additional 1,014 shares during the period. Finally, Enterprise Financial Services Corp increased its position in shares of Monsanto by 4.5% in the second quarter. Enterprise Financial Services Corp now owns 1,335 shares of the company’s stock worth $138,000 after buying an additional 57 shares during the period. 73.94% of the stock is owned by hedge funds and other institutional investors.
Monsanto Co. (NYSE:MON) traded up 0.363% during mid-day trading on Wednesday, hitting $102.762. The company had a trading volume of 264,927 shares. Monsanto Co. has a one year low of $83.73 and a one year high of $114.26. The company’s 50 day moving average price is $100.97 and its 200-day moving average price is $104.18. The company has a market cap of $45.01 billion, a PE ratio of 34.392 and a beta of 1.01.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.09. The company had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. Monsanto’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.19) earnings per share. Equities research analysts anticipate that Monsanto Co. will post $4.73 EPS for the current fiscal year.
A number of equities analysts recently issued reports on the company. Goldman Sachs Group Inc. raised Monsanto from a “sell” rating to a “neutral” rating and set a $104.00 price target for the company in a report on Tuesday, September 27th. Piper Jaffray Cos. set a $128.00 price target on Monsanto and gave the company a “buy” rating in a report on Thursday, September 15th. Argus reissued a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a report on Sunday, October 9th. Jefferies Group reissued a “buy” rating on shares of Monsanto in a report on Tuesday, September 6th. Finally, Citigroup Inc. increased their price objective on Monsanto from $112.00 to $116.00 and gave the company a “neutral” rating in a report on Friday, August 19th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and fifteen have assigned a buy rating to the company. Monsanto currently has a consensus rating of “Buy” and a consensus target price of $114.06.
In other news, EVP Robert T. Fraley sold 80,631 shares of Monsanto stock in a transaction on Friday, October 14th. The stock was sold at an average price of $102.04, for a total transaction of $8,227,587.24. Following the transaction, the executive vice president now owns 38,711 shares in the company, valued at $3,950,070.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Charles S. Mcmillan purchased 3,500 shares of the stock in a transaction dated Monday, October 10th. The shares were acquired at an average price of $103.23 per share, for a total transaction of $361,305.00. Following the acquisition, the director now directly owns 64,009 shares of the company’s stock, valued at approximately $6,607,649.07. The disclosure for this purchase can be found here. Insiders own 0.88% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.